Jayanshu Jain

424 total citations
10 papers, 59 citations indexed

About

Jayanshu Jain is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jayanshu Jain has authored 10 papers receiving a total of 59 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Jayanshu Jain's work include Acute Myeloid Leukemia Research (2 papers), Renal cell carcinoma treatment (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Jayanshu Jain is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Renal cell carcinoma treatment (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). Jayanshu Jain collaborates with scholars based in United States, Malaysia and Greece. Jayanshu Jain's co-authors include Rohan Garje, Rejnish Kumar, Vignesh T. Packiam, Adithya Chennamadhavuni, Sarah L. Mott, Dimitrios Makrakis, Mohammed Milhem, Eric McLaughlin, Meera Patel and Tara L. Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jayanshu Jain

7 papers receiving 56 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayanshu Jain United States 4 28 24 22 18 17 10 59
Terence Roberts United States 3 14 0.5× 25 1.0× 17 0.8× 7 0.4× 27 1.6× 4 47
Joel Berends United States 4 33 1.2× 36 1.5× 17 0.8× 7 0.4× 36 2.1× 7 68
Sylvia Mitchell Canada 6 24 0.9× 19 0.8× 30 1.4× 20 1.1× 8 0.5× 12 72
Warren Grant United Kingdom 7 25 0.9× 14 0.6× 16 0.7× 44 2.4× 28 1.6× 11 92
Běla Malinová Czechia 5 21 0.8× 11 0.5× 12 0.5× 5 0.3× 15 0.9× 21 55
C. Lafond France 4 21 0.8× 36 1.5× 23 1.0× 4 0.2× 45 2.6× 6 63
Yungan Tao France 7 29 1.0× 58 2.4× 35 1.6× 6 0.3× 34 2.0× 18 87
Kavita Nawale India 5 19 0.7× 25 1.0× 15 0.7× 3 0.2× 19 1.1× 17 46
Lyra Del Rosario United Kingdom 5 27 1.0× 65 2.7× 37 1.7× 6 0.3× 37 2.2× 6 86
Petra Flygare Sweden 5 34 1.2× 9 0.4× 23 1.0× 7 0.4× 39 2.3× 8 73

Countries citing papers authored by Jayanshu Jain

Since Specialization
Citations

This map shows the geographic impact of Jayanshu Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayanshu Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayanshu Jain more than expected).

Fields of papers citing papers by Jayanshu Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayanshu Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayanshu Jain. The network helps show where Jayanshu Jain may publish in the future.

Co-authorship network of co-authors of Jayanshu Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Jayanshu Jain. A scholar is included among the top collaborators of Jayanshu Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayanshu Jain. Jayanshu Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
3.
Jain, Jayanshu, et al.. (2023). Characteristics and Outcomes of Patients with DDX41-Mutated Acute Myeloid Leukemia: A Single-Center Experience. Blood. 142(Supplement 1). 4227–4227. 1 indexed citations
4.
Packiam, Vignesh T., et al.. (2022). Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 11. 786307–786307. 5 indexed citations
5.
Koshkin, Vadim S., Yilun Sun, Dory Freeman, et al.. (2021). Efficacy of enfortumab vedotin in advanced urothelial cancer: Retrospective analysis of the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) Study.. Journal of Clinical Oncology. 39(6_suppl). 443–443. 4 indexed citations
6.
Makrakis, Dimitrios, Leonidas Nikolaos Diamantopoulos, Vadim S. Koshkin, et al.. (2021). Association between sites of metastases (mets) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).. Journal of Clinical Oncology. 39(6_suppl). 445–445. 3 indexed citations
7.
Jain, Jayanshu, et al.. (2020). Evaluation of Checkpoint Inhibitors in Cancer Patients With End-stage Renal Disease on Hemodialysis: Case Series and Review of the Literature. Journal of Immunotherapy. 43(8). 244–249. 9 indexed citations
8.
Jain, Jayanshu, et al.. (2020). 427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma. SHILAP Revista de lepidopterología. A260.1–A260. 1 indexed citations
9.
Jain, Jayanshu, et al.. (2011). ROLE MATRIX METALLOPROTEINASES 2 IN GLIOMA PATIENT SPECIFIC IN AGE, GENDER & MENOPAUSAL STATUS. 3(3). 38–44. 1 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terence Roberts Breakdown of academic impact, for papers by Joel Berends Breakdown of academic impact, for papers by Sylvia Mitchell Breakdown of academic impact, for papers by Warren Grant Breakdown of academic impact, for papers by Běla Malinová Breakdown of academic impact, for papers by C. Lafond Breakdown of academic impact, for papers by Yungan Tao Breakdown of academic impact, for papers by Kavita Nawale Breakdown of academic impact, for papers by Lyra Del Rosario Breakdown of academic impact, for papers by Petra Flygare
Rankless by CCL
2026